Matches in Nanopublications for { ?s ?p "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP648090.RAaescmA-QVRpUiclIy73lQCsQCX_E7X7MsOJorEKF_Qw130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648090.RAaescmA-QVRpUiclIy73lQCsQCX_E7X7MsOJorEKF_Qw130_provenance.
- NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492787.RAB6v8aiSH0-4hnPJI0gVVJCmXNbazHGAZmSIBQf95Gtw130_provenance.
- NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804251.RABRiwhdrststEN7IkkcUl2vwcsbvynAusJpUG3KsZt7Y130_provenance.
- NP804252.RAA3x7KpugrkofWmO2UkP5i0SzUmEODtoNT3fXjo29ZUk130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804252.RAA3x7KpugrkofWmO2UkP5i0SzUmEODtoNT3fXjo29ZUk130_provenance.
- NP492915.RAQTWqBWu40SJFnv9Y0p5Qd65R-pAu6D-latHDRbxHojo130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492915.RAQTWqBWu40SJFnv9Y0p5Qd65R-pAu6D-latHDRbxHojo130_provenance.
- NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804249.RA1bzW5M9C1CHDJToBEjQJ6xv1eB2nYuwRoPqIaDr5pCI130_provenance.
- NP804254.RA7xbjSCfyJ_nJ_EiCOXJZSmGTDyfEsn9hXxUGjFSWNH0130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804254.RA7xbjSCfyJ_nJ_EiCOXJZSmGTDyfEsn9hXxUGjFSWNH0130_provenance.
- NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492823.RAPwqiMyEWwIhVo_iXJCxSZqOL35sFet2R2VmbVJXxUv8130_provenance.
- NP493236.RAgElZpuAafwKcWNN2KS18F3UVeSTMTQfZXF40y2btGms130_assertion description "[Hypodense activated eosinophils have been described in various diseases such as parasitic or allergic diseases, hypereosinophilic syndrome (HES) associated in some cases to myeloproliferative markers, and more recently described in patients undergoing recombinant IL2 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493236.RAgElZpuAafwKcWNN2KS18F3UVeSTMTQfZXF40y2btGms130_provenance.